Table 1.
Baseline characteristics for the Saudi Initiative for Asthma group and the Global Initiative for Asthma group
| Characteristics | SINAa group | GINAb group | p value |
|---|---|---|---|
| Number of patients | 45 | 45 | |
| Age, years (± SD) | 42.9 (± 13.4) | 42.3 (± 12.6) | 0.840 |
| Gender | |||
| - Male, No. (%) | 14 (31.1%) | 19 (42.2%) | 0.274 |
| - Female, No. (%) | 31 (68.9%) | 26 (57.8%) | |
| Body mass index, No. (± SD) | 32.6 (± 7.4) | 34.0 (± 7.3) | 0.370 |
| Disease duration, years (± SD) | 10.9 (± 9.3) | 10.1 (± 8.6) | 0.630 |
| Respiratory Symptoms | |||
| - Cough, No. (%) | 27 (60.0%) | 22 (48.9%) | 0.290 |
| - Shortness of breath, No. (%) | 10 (22.2%) | 15 (33.3%) | 0.239 |
| - Wheezing, No. (%) | 7 (15.6%) | 9 (20.0%) | 0.581 |
| Asthma attacks in the past 4 weeks, No. (%) | 1.5 (± 1.1) | 1.8 (± 1.5) | 0.378 |
| Initial visit Peak Flow meter, value (± SD) (L/min) | 343.1 (± 129.5) | 362.9 (± 148.8) | 0.143 |
| Initial visit Forced Expiratory volume in 1 second, Percentage of normal (± SD) | 81.4% (± 17.1) | 84.3% (± 16.2) | 0.269 |
| Initial visit asthma control test score, score (± SD) | 17.6 (± 4.5) | 17.8 (± 3.6) | 0.776 |
a SINA: Saudi Initiative for Asthma; b GINA: Global Initiative for Asthma